Indefinite Delivery Contract 36C25726D0031
Award Date 12/12/25
Last Date to Order 12/11/26
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- Humco Holding Group, Inc. was awarded a Federal Supply Schedule contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB) by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. This multiple award contract, effective January 15, 2020, with an ultimate completion date of March 14, 2027, carries a ceiling value of $4,400,000.00 and does not utilize any small business set-asides. The contract covers pharmaceutical and hematology-related...
- The Department of Veterans Affairs awarded a Federal Supply Schedule contract to Vyera Pharmaceuticals, LLC to procure drugs, pharmaceuticals, and related hematology products. The potential value of this multiple award schedule is $3.5 million with an ordering period through September 2029. Additionally, the National Acquisition Center established a single award Blanket Purchase Agreement with Vyera Pharmaceuticals on behalf of the Veterans Health Administration. Valued at $450,000, this BPA...
- The Department of Veterans Affairs awarded a multiple-award federal supply schedule contract to Amryt Pharmaceuticals Inc. with a potential value of $225,000. The schedule is for pharmaceuticals and hematology-related products under contract number 65 IB. This enables ordering through September 2028. Additionally, the Department of Veterans Affairs National Acquisition Center awarded a single-award blanket purchase agreement to Amryt Pharmaceuticals with a value of up to $1,000,000. The BPA...
- The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract, valued up to $10,813,880, to Radha Pharmaceuticals Inc., a minority-owned small business manufacturer, to provide Carbidopa/Levodopa sustained-action tablets. The contract has a base period of one year from May 23, 2025 to May 22, 2026, with four one-year option periods. The contract aims to secure an uninterrupted supply of these pharmaceutical products for the VA, Department...
- The National Acquisition Center of the U.S. Department of Veterans Affairs (VA) awarded a single-award Indefinite Delivery Contract (IDC) to Mylan Pharmaceuticals Inc. to provide Loperamide Hydrochloride (HCL) capsules. The contract has a potential value of $8,960,715.85 and a period of performance from July 30, 2020 to July 29, 2025, with four one-year option periods. The contracted products will be distributed through the VA's and Department of Defense's (DoD) respective Pharmaceutical Prime...
- This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs (VA), is for the procurement of pharmaceutical and hematology-related products. The contract has a ceiling value of $8,169,800.00 and a period of performance through February 14, 2025. The prime contractor, Romark Laboratories, L.C., is a for-profit foreign-owned organization that was awarded this multiple-award FSS contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule. The contract does...
- Global Health Products, Inc. has been awarded a multiple-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center with a ceiling value of $4.93M and a performance period from November 1, 2025, through October 31, 2026, with four one-year renewal options. This civilian agency procurement requires no set-asides and was issued under full and open competition. The contract supports the Department of Veterans Affairs' requirement to supply standardized...
- This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business that is certified as an economically disadvantaged woman-owned small business. The contract has a total ceiling value of $3,129,016.00 and a period of performance from November 16, 2020 to November 15, 2025. It is a single-award IDC that allows for the ordering of various pharmaceutical products...
- On January 20, 2026, the Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Hikma Pharmaceuticals USA Inc. (doing business as FKA West-Ward Pharmaceuticals) for the supply of Hydralazine Hydrochloride Injections at a ceiling value of $2.37 million. The contract encompasses a one-year base ordering period from January 20, 2026, through January 19, 2027, with four one-year optional renewal periods extending through January 19, 2031....
- Ardelyx, Inc., a pharmaceutical company headquartered in Fremont, California, has been awarded a $32.5 million Blanket Purchase Agreement (BPA) by the National Acquisition Center under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The BPA was awarded on April 30, 2024, with an ultimate completion date of April 29, 2027, and represents a single-award, non-set-aside contract. Under this IDV, Ardelyx supplies XPHOZAH (tenapanor), a specialized medication indicated for the...
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 36C25726D0031-36C25726N0331 | Low Cost RX LLC | $63.0k | 4/8/26 | 12/11/26 | 4/28/26 |